• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    A new reports shows that Wisconsin Sen. Ron Johnson, running for reelection, is the most productive senator when it comes to getting legislation passed. (AP Photo/Scott Bauer, File)
    Healthcare

    Dispute over helping the terminally ill

    Paige Winfield Cunningham -
    June 27, 2016 4:01 am
    0
    AIDS advocates participate in a rolling protest caravan in Rancho Palos Verdes, Calif., on June 8, targeting Gilead Sciences over its drug pricing and policies during the drug giant's presentation at Goldman Sachs' Annual Healthcare Conference at the exclusive Terranea Resort. The protest followed a Los Angeles Times article that revealed Gilead's patent manipulation in order to maximize profits on its drugs containing tenofovir, a key HIV/AIDS drug. (AIDS Healthcare Foundation via AP)
    Healthcare

    Drug makers fight Calif. price caps

    Robert King -
    June 13, 2016 4:01 am
    0
    Sens. Susan Collins, R-Maine, and Claire McCaskill, D-Mo., wrote to five manufacturers of naloxone on Friday to ask what the drug companies are doing to preserve access to the generic product. (AP Photo/Mel Evans, File)
    Healthcare

    Senators want cheap prices for overdose antidote

    Robert King -
    June 6, 2016 9:02 pm
    0
    Shkreli was hit on Friday with a new indictment that included a new conspiracy charge. The charges are related to allegations that Shkreli and his former attorney Evan Greebel took stock from one company to prop up another. (Pete Marovich/Bloomberg, File)
    Healthcare

    ‘Pharma bro’ pleads not guilty to new charges

    Robert King -
    June 6, 2016 7:32 pm
    0
    Benjamin Brafman, right, attorney for pharmaceutical chief Martin Shkreli, foreground, speaks on Capitol Hill on Feb. 4 during a House Committee on Oversight and Reform Committee hearing on rising drug prices. Shkreli refused to testify before U.S. lawmakers who excoriated him over severe hikes for a drug sold by a company that he acquired. (AP Photo/Susan Walsh)
    Healthcare

    Lawmakers feel the pain over drug prices

    Paige Winfield Cunningham -
    June 6, 2016 4:01 am
    0
    Former drug company CEO Martin Shrkeli has been hit with a new conspiracy charge. (AP Photo/Craig Ruttle)
    Crime

    ‘Pharma Bro’ slapped with another charge

    Daniel Chaitin -
    June 4, 2016 5:03 pm
    0
    The agency on Thursday finalized a rule that streamlines the process of applying for compassionate use, which enables a patient to get non-approved treatments when there isn’t any other option. (iStock photo)
    Healthcare

    FDA speeds up process of applying for last resort drugs

    Robert King -
    June 2, 2016 2:57 pm
    0
    Rep. Mike Bishop, R-Mich., said Wednesday the administration hasn't answered his questions about why it didn't grant emergency funds to victims in a 2012 outbreak of meningitis. (AP Photo/Susan Walsh, File)
    Healthcare

    Lawmaker wants funds for victims of tainted drug scandal

    Robert King -
    June 1, 2016 2:50 pm
    0
    Republicans want the Obama administration to allow drug firms to advertise unapproved drug uses to doctors. (AP Photo/Sue Ogrocki, File)
    Healthcare

    House lawmakers push HHS on drug advertising

    Robert King -
    May 26, 2016 10:58 pm
    0
    The Food and Drug Administration approved Probuphine, which is an implant intended to provide a low-level dose of the opioid addiction treatment buprenorphine. (Screenshot)
    Healthcare

    FDA approves new way to fight opioid addiction

    Robert King -
    May 26, 2016 9:29 pm
    0
    1...122123124...157Page 123 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.